Skip to main content

Initial retrospective analysis of mechanisms of FOLFIRINOX resistance using clinical and molecular data from the Know Your Tumor (KYT) pancreatic ductal adenocarcinoma (PDAC) cohort.

Publication ,  Conference
Davison, JM; Mayhew, G; Beebe, K; Eisner, JR; Ladnier, D; Collisson, EA; Matrisian, LM
Published in: CANCER RESEARCH
2021

Duke Scholars

Published In

CANCER RESEARCH

EISSN

1538-7445

ISSN

0008-5472

Publication Date

2021

Volume

81

Issue

22

Start / End Page

1 / 2

Related Subject Headings

  • Oncology & Carcinogenesis
  • 3211 Oncology and carcinogenesis
  • 3101 Biochemistry and cell biology
  • 1112 Oncology and Carcinogenesis
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Davison, J. M., Mayhew, G., Beebe, K., Eisner, J. R., Ladnier, D., Collisson, E. A., & Matrisian, L. M. (2021). Initial retrospective analysis of mechanisms of FOLFIRINOX resistance using clinical and molecular data from the Know Your Tumor (KYT) pancreatic ductal adenocarcinoma (PDAC) cohort. In CANCER RESEARCH (Vol. 81, pp. 1–2).
Davison, James M., Greg Mayhew, Kirk Beebe, Joel R. Eisner, Dennis Ladnier, Eric A. Collisson, and Lynn M. Matrisian. “Initial retrospective analysis of mechanisms of FOLFIRINOX resistance using clinical and molecular data from the Know Your Tumor (KYT) pancreatic ductal adenocarcinoma (PDAC) cohort.” In CANCER RESEARCH, 81:1–2, 2021.

Published In

CANCER RESEARCH

EISSN

1538-7445

ISSN

0008-5472

Publication Date

2021

Volume

81

Issue

22

Start / End Page

1 / 2

Related Subject Headings

  • Oncology & Carcinogenesis
  • 3211 Oncology and carcinogenesis
  • 3101 Biochemistry and cell biology
  • 1112 Oncology and Carcinogenesis